Syensqo and Allozymes, a Singapore-based enzyme engineering start-up, have signed a Memorandum of Understanding to leverage both companies' strengths in biotechnology to develop advanced biosolutions for the personal care (especially skin care) and home care markets.
See related: Syensqo Invests in Green Solvents Producer Startup Bioeutectics
According to Syensqo, Allozymes brings to the partnership a unique ultra-high throughput microfluidics platform for the engineering of enzymes and microbes. This reportedly will enable the rapid and cost-effective development of bio-manufactured ingredients and bioprocesses, "setting a new standard for innovation and sustainability in the industry."
Syensqo will apply its application and market access expertise, including strategies to rapidly extend biotech ingredient solutions into beauty. The recent acquisition of South Korean ceramides specialist JinYoung Bio demonstrates this strength.
“By combining Allozymes technological capabilities with Syensqo's application and market access expertise, we are poised to create groundbreaking solutions that will not only benefit the home and personal care market, but also contribute to a more sustainable future,” said Thomas Canova, head of renewable materials and biotechnology growth platform at Syensqo.
“Our partnership with Syensqo embodies our mutual commitment to a sustainable future, leveraging biotechnology to enable cleaner, greener processes, ensuring our actions today contribute to a healthier planet for future generations, ..." added Peyman Salehian, Ph.D., CEO and co-founder at Allozymes.
See also: Syensqo's Latest Ingredients in Skin and hair Care at in-cosmetics Global
